A phase II trial of postoperative radiotherapy (RT), cisplatin, and panitumumab in patients with high-risk, resected locally advanced squamous cell carcinoma of the head and neck (SCCHN).Robert L. Ferris, Athanassios Argiris, Dwight E. Heron et al.|Journal of Clinical Oncology|2010Cited by 8